$1.5M
The strategic backing from Hamamatsu Ventures will support international expansion and technological development.
iLoF
iLoF develops an artificial intelligence powered photonics platform for personalised medicine.
$5.7MTotal raised
iLoF operates a digital health platform that uses artificial intelligence and photonics to accelerate personalised medicine. The firm focuses on transforming healthcare and improving early disease detection.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from iLoF's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Luis Valente
Co-Founder and CEO
Luis is the chief executive and co-founder of iLoF. He also advises ventures through roles with the European Innovation Council and Startup World Cup.
LinkedIn
Joana Paiva
Joana is chief executive officer at Seedsight and a founder of iLoF. She brings academic and leadership experience, holding roles as an auxiliar professor at the University of Porto and an evaluator for the European Commission.
LinkedInMM
Mehak Mumtaz
Co-Founder and COO
Mehak is co-founder and COO of iLoF and a lecturer at the University of Oxford. Her background includes strategy consulting at EY-Parthenon and health innovation fellowships.
LinkedInInvestors
- $1.5M
- £3.4M
- £790K
Funding history
£3.4M
iLoF secures 3.38m in seed funding led by Faber to accelerate personalized drug discovery platforms.
The seed round was led by Faber with participation from international venture funds to support clinical trial operations.
£790K
The Oxford startup raised the capital from Microsoft's venture fund and Mayfield following its success in the Female Founders Competition.